https://www.selleckchem.com/products/vt103.html
ations remain, mainly at the gene expression, which still reveals the impact of HIV infection in these patients. Data on placental transfer is lacking for the recent HIV integrase inhibitors, bictegravir and cabotegravir, although their future use in pregnancy is to be expected. The objective of this study was to determine their transplacental pharmacokinetics. Maternal-to-fetal transfer was investigated using the open-circuit ex-vivo dually perfused human cotyledon model. Cabotegravir or bictegravir was added to a maternal perfusate cont
Like
Comment
Share
